TABLE 3.
Grades | Guideline for the management |
G1 | • Consider holding ICIs Monitor symptoms every 2–3 days |
• May offer one repeat CT in 3–4 weeks | |
• In patients who have had baseline testing, may offer a repeat spirometry/DLCO in 3–4 weeks | |
○ If improvement is observed, continue to follow up | |
○ If condition worsens, treat as G2 or 3–4 | |
G2 | • Hold ICIs until resolution to G1 or less |
• Consider infectious workup: nasal swab for potential viral pathogens sputum culture, blood culture, and urine culture | |
• Consider chest CT with contrast Repeat chest CT in 3–4 weeks | |
• Consider empirical antibiotics if infection has not yet been fully excluded | |
• Prednisone IV 1–2 mg/kg/day | |
○ If improvement is observed, start slow steroid taper by 5 to 10 mg/week over 4 to 6 weeks | |
○ If condition worsens, treat as G3–4 | |
G3/G4 | • Permanently discontinue ICIs |
• Pulmonary consultation for bronchoscopy with BAL | |
Consider biopsies for atypical lesions Methylprednisolone IV 2–4 mg/kg/day | |
○ If improvement is observed, taper corticosteroids over 4–6 weeks | |
○ If not improving or worsening after 48 h: add infliximab IV 5 mg/kg | |
or MMF IV 1 g BID | |
or IVIG for 5 days | |
or cyclophosphamide |
ICIs, immune checkpoint inhibitors; CT, computed tomography; DLCO, carbon monoxide diffusing capacity; IV, intravenous; BAL, bronchoalveolar lavage; MMF, mycophenolate mofetil; BID, two times daily; and IVIG, intravenous immunoglobulin.